Introduction  

​

Coronary Artery Bypass Grafting (CABG) is a surgical procedure used to treat advanced coronary artery disease by replacing blocked coronary arteries with healthy blood vessels. With the field’s multitude of innovations, CABG is considered one of the most technologically advanced procedures. Despite this, however, surgical success remains heavily dependent on one factor: anatomical variability [1, 2]. 

 

Background

​

     Anatomical variability in CABG refers to variations of the coronary arteries in vessel size, dominance, branching patterns, and position [1]. Patient-specific coronary anatomy significantly influences the outcome of CABG, necessitating careful consideration in surgical planning and treatment [1,2]. Understanding these variations is crucial for optimizing surgical outcomes and minimizing both complications and mortality [3]. As a result, this study aims to analyze the effects of coronary artery anatomical variability in CABG decisions, identifying optimal approaches and applications to minimize the effects of such variation.

 

Methods

​

     This study employed an analysis of clinical literature from databases including PubMed and Google Scholar to evaluate the impact of anatomical variability on revascularization. Inclusion criteria targeted research discussing coronary artery anomalies, vessel size impacts on graft patency, and bioethical frameworks in cardiothoracic surgery. An ethical reflection was then performed, applying the four major medical ethic principles (autonomy, beneficence, non-maleficence, and justice) to surgical decision-making when patient anatomy deviates from standard clinical guidelines.

 

Results

     Findings indicate that reduced vessel size and moderate stenosis significantly influence surgical decisions. Small target vessels (≤1.5 to 2.0 mm) are linked to higher graft-occlusion rates and a 1.3-fold increase in failure risk, requiring altered revascularization plans to maintain patency [4, 7]. Moderate stenosis brought about competitive flow, where native blood flow competes with the graft, leading to increased arterial graft failure and a more than doubled risk of early occlusion [5, 8, 9]. 

     The best approaches included individualized consideration of graft type and anastomotic technique. Intraoperative Transit Time Flow Measurement (TTFM) reliably identified failing grafts and improved revision rates, while the targeted use of high-resolution imaging such as Coronary Computed Tomography Angiography (CCTA) and Fractional Flow Reserve derived from Computed Tomography (FFRCT) optimized preoperative planning [1, 4, 6]. Emerging computational flow modeling also enhanced prediction of competitive flow mismatch. Ethically, variability and reliance on imaging raises concerns regarding equitable treatment, informed consent, and adherence to transparency [5]. Anatomical constraints often force deviation from guideline-preferred grafts and limit the ability to provide complete revascularization, necessitating targeted assessment and systematic quality checking [2, 6].

 

Conclusion

​

     Overall, anatomical variability has shown a great effect on CABG outcomes, with the best approaches incorporating individualized adjustment and targeted planning. To achieve ethically sound decision making, there is a need to rely on maximizing catered benefit while minimizing harm through specific anatomical assessment and intraoperative quality verification.

 

Ethical Reflection

​

     To truly reflect on the clinical implications of anatomical variability, the four pillars of medical ethics must be considered: Autonomy (respecting the patient's right to choose), Beneficence (acting in the patient's best interest), Non-maleficence (doing no harm), and Justice (ensuring fairness and equity).

     The presence of anatomical variability complicates the standard ethical framework of cardiac care. Informed consent is particularly critical because if a patient possesses anatomy that increases the risk of graft failure, the principle of Autonomy requires that they be informed of the lessened probability of long-term success compared to standard cases [10]. Often, patients enter surgery with a "prognostic myth" that bypass guarantees a total cure, but anatomical constraints may force a deviation from guideline-preferred grafts, limiting complete revascularization [5, 10].

     From the perspective of Beneficence and Non-maleficence, the surgeon must weigh the potential for symptom relief against the harm of a failed procedure. Revascularizing a vessel with moderate stenosis may violate Non-maleficence if the graft is likely to fail due to competitive flow, potentially subjecting the patient to surgical risk without tangible benefit [8, 9]. Finally, Justice concerns arise regarding equitable access to advanced imaging. Patients at facilities lacking high resolution CCTA or TTFM may receive less precise planning, highlighting a systemic inequality in how anatomical variability is managed across different settings [5, 6]. True transparency between doctor and patient is essential to ensure that the final surgical plan aligns with the patient's values and clinical reality, thereby offering the most optimized path to considering anatomical variabilities [2, 10].

​Works Cited

1. Yarlagadda G, Br N. Significance of coronary artery anomalies and variants found on coronary computed tomography angiography. Hong Kong J Radiol. 2020;23(3):208-217. doi:10.12809/HKJR2016957

2. Kesieme EB, Omoregbee B, Ngaage DL, Danton M. Comprehensive review of coronary artery anatomy relevant to cardiac surgery. Curr Cardiol Rev. 2024;21. doi:10.2174/011573403x321942241023112517

3. Alexander JP, Smith PK. Coronary-artery bypass grafting. N Engl J Med. 2016;375(20):1954-1964. doi:10.1056/NEJMra1406944

4. Angelini P, Uribe C. Can we talk? The residual, urgent questions about surgery for coronary artery anomalies. JTCVS Open. 2022;11:127-128. doi:10.1016/j.xjon.2022.04.027

5. Wilson T, James MT, Southern DA, et al. Hospital and physician variability in revascularization decisions and outcomes for patients with 3-vessel and left main coronary artery disease. J Am Heart Assoc. 2024;13(18). doi:10.1161/JAHA.123.035356

6. Leape LL, Park RE, Bashore TM, et al. Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures. Acc Curr J Rev. 2000;9(3):95-97. doi:10.1016/S1062-1458(00)00053-2

7. Zaikovskii V, Shiryaev AA, Akchurin RS, et al. Early and annual outcomes of coronary artery bypass grafting in patients with coronary arteries less than 1.5 mm and their comparison with postoperative outcomes in patients with larger coronary arteries. Kardiologicheskiy Vestnik. 2022;17(1):75. doi:10.17116/cardiobulletin20221701175

8. Kim JS, Kang YJ, Sohn SH, et al. Occurrence rate and fate of competitive flow of the left internal thoracic artery used in Y-composite grafts. JTCVS Open. 2022;3:11-20. doi:10.1016/j.xjon.2022.06.006

9. Bazylev VV, Nemchenko EV, Rosseĭkin EV, et al. Flowmetric and angiographic predictors of occlusion of coronary bypass grafts. Angiol Sosud Khir. 2018;24(1):33-39.

10. Chandrasekharan S, Taggart DP. Informed consent for interventions in stable coronary artery disease: problems, etiologies, and solutions. Eur J Cardiothorac Surg. 2011;39(6):e146-e152. doi:10.1016/j.ejcts.2010.08.033